Effects of danazol and progesterone on sex hormone-binding globulin mRNA expression in human endometrial cancer cell line Ishikawa

R Misao, Ryou Misao, Yoshihito Nakanishi, Y Nakanishi, J Fujimoto, Jiro Fujimoto, T Tamaya, Teruhiko Tamaya
The Journal of steroid biochemistry and molecular biology · 1997 · vol. 62(4) , pp. 321–325 · doi:10.1016/s0960-0760(97)00045-9 · PMID:9408086 · W1996394634
Lab / animal OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Danazol and progesterone differentially regulate sex hormone-binding globulin mRNA expression in the Ishikawa human endometrial cancer cell line.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To ascertain one of the biological effects of danazol and progesterone on the uterine endometrial cancer cell line, Ishikawa, we investigated the effects of these steroids on sex hormone-binding globulin (SHBG) mRNA expression by competitive reverse transcription-polymerase chain reaction-Southern blot analysis (RT-PCR-SBA). Estradiol-17beta (E2) in any concentration given did not exert any significant effect on the expression of SHBG mRNA. Danazol and progesterone significantly (P < 0.05) suppressed the expression of SHBG mRNA dose-dependently starting at a concentration of 10(-6) and 10(-8) M, respectively. Progesterone, in a low concentration (10[-10] M) with E2 (10[-8] M), significantly (P < 0.05) increased the expression of SHBG mRNA, but danazol did not. In contrast, danazol and progesterone in high concentrations (10[-6] to 10[-5] M) with E2 (10[-8] M) significantly (P < 0.05) suppressed its expression. The time course study showed the time-dependent decrease of SHBG mRNA level by danazol and progesterone (10[-6] M) with or without E2 (10[-8] M), except for a temporal increase by progesterone. These findings suggest that danazol and progesterone in a superphysiological milieu down-regulate the intracellular SHBG-related steroidal actions, and that progesterone in a physiological milieu with estrogen up-regulates it in a hormone-dependent cell line. A decrease of intracellular SHBG caused by high-dose danazol or progesterone might partly contribute to the abolition of the intracellular estrogen-dominant milieu, and be related to the inhibition of estrogen-dependent growth of some endometrial cancer cells.

My notes (saved in your browser only)

MeSH descriptors

Danazol Estrogen Antagonists Progesterone RNA, Messenger Sex Hormone-Binding Globulin Adenocarcinoma Adenocarcinoma Danazol Dose-Response Relationship, Drug Down-Regulation Endometrial Neoplasms Endometrial Neoplasms Estrogen Antagonists Female Humans Polymerase Chain Reaction Progesterone RNA, Messenger RNA, Messenger Sex Hormone-Binding Globulin

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (40)

Source provenance

openalex
last seen: 2026-05-11T05:50:48.314143+00:00
pubmed
last seen: 2026-10-08T22:00:28.864438+00:00
unpaywall
last seen: 2026-10-17T06:24:38.187582+00:00
License: CC0 · commercial use OK